BCR-ABL1, Minor (p190), Quantitative
2005016
Ordering Recommendation
Order in cases of Philadelphia chromosome positive (Ph+) lymphoblastic leukemia to quantify the BCR-ABL1 p190 fusion form. For CML, use BCR-ABL1, Major (p210), Quantitative, (2005017).
Mnemonic
BCR MIN
Methodology
Quantitative Reverse Transcription Polymerase Chain Reaction
Performed
RNA isolation: Sun-Sat
Assay:
Sun, Tue, Thu
Reported
5-7 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Lavender (EDTA) or bone marrow (EDTA).  
Specimen Preparation
Transport 5 mL whole blood or 3 mL bone marrow. (Min: 1 mL whole blood or 1 mL bone marrow) Specimens must be received within 48 hours of collection due to lability of RNA.  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Serum or plasma. Specimens collected in anticoagulants other than EDTA. Severely hemolyzed specimens. Frozen or clotted specimens.  
Remarks
  
Stability
Ambient: 1 hour; Refrigerated: 48 hours; Frozen: Unacceptable  
Reference Interval
   
Interpretive Data
Refer to report.

See Compliance Statement D: www.aruplab.com/CS  
Note
For p210 fusion form (major breakpoint), order BCR-ABL1, Major (p210), Quantitative (ARUP test code 2005017).
CPT Code(s)
81207
Components
Component Test Code*Component Chart Name
0051095BCR-ABL1, t(9;22) Source
2005007BCR-ABL1, Minor (p190) Result
2005008BCR-ABL1/ABL1, Minor (p190) Quant Ratio
2005009EER BCR-ABL1, Minor (p190)
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • p190;
  • PH1
  • philadelphia chromosome
  • Philadelphia MS
  • t(9;22)